554 related articles for article (PubMed ID: 11410858)
21. Engineering subtilisin into a fluoride-triggered processing protease useful for one-step protein purification.
Ruan B; Fisher KE; Alexander PA; Doroshko V; Bryan PN
Biochemistry; 2004 Nov; 43(46):14539-46. PubMed ID: 15544324
[TBL] [Abstract][Full Text] [Related]
22. Comparison of two chemical cleavage methods for preparation of a truncated form of recombinant human insulin-like growth factor I from a secreted fusion protein.
Forsberg G; Baastrup B; Brobjer M; Lake M; Jörnvall H; Hartmanis M
Biofactors; 1989 Dec; 2(2):105-12. PubMed ID: 2696476
[TBL] [Abstract][Full Text] [Related]
23. Amino-terminal charge affects the periplasmic accumulation of recombinant heregulin/EGF hybrids exported using the Escherichia coli alkaline phosphatase signal sequence.
Campion SR; Elsasser E; Chung R
Protein Expr Purif; 1997 Aug; 10(3):331-9. PubMed ID: 9268680
[TBL] [Abstract][Full Text] [Related]
24. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
[TBL] [Abstract][Full Text] [Related]
25. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
26. Production of a recombinant hybrid hemoflavoprotein: engineering a functional NADH:cytochrome c reductase.
Barber MJ; Quinn GB
Protein Expr Purif; 2001 Nov; 23(2):348-58. PubMed ID: 11676611
[TBL] [Abstract][Full Text] [Related]
27. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
[TBL] [Abstract][Full Text] [Related]
29. Purification of human big endothelin 1 derived through cleavage with collagenase and dipeptidylpeptidase IV from a fusion protein expressed in Escherichia coli.
Becker A; Theuring F; Gottwald M; Kauser K; Schleuning WD; Donner P
Protein Expr Purif; 1994 Feb; 5(1):50-6. PubMed ID: 7909463
[TBL] [Abstract][Full Text] [Related]
30. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.
Stabach PR; Cianci CD; Glantz SB; Zhang Z; Morrow JS
Biochemistry; 1997 Jan; 36(1):57-65. PubMed ID: 8993318
[TBL] [Abstract][Full Text] [Related]
31. Production, in vitro characterisation, in vivo clearance, and tissue localisation of recombinant barramundi (Lates calcarifer) insulin-like growth factor II.
Degger B; Richardson N; Collet C; Upton Z
Gen Comp Endocrinol; 2001 Jul; 123(1):38-50. PubMed ID: 11551116
[TBL] [Abstract][Full Text] [Related]
32. Peptide design aided by neural networks: biological activity of artificial signal peptidase I cleavage sites.
Wrede P; Landt O; Klages S; Fatemi A; Hahn U; Schneider G
Biochemistry; 1998 Mar; 37(11):3588-93. PubMed ID: 9530285
[TBL] [Abstract][Full Text] [Related]
33. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
Brassard DL; Lamb RA
Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
[TBL] [Abstract][Full Text] [Related]
34. Independently expressed N-terminal pro-domain of aqualysin I precursor complements the folding of its mature domain to active form in Escherichia coli.
Kim JY; Choi YL; Cho YS; Kim CH; Lee YC
J Basic Microbiol; 2002; 42(3):181-9. PubMed ID: 12111745
[TBL] [Abstract][Full Text] [Related]
35. Expression, refolding, and purification of recombinant human granzyme B.
Lorentsen RH; Fynbo CH; Thøgersen HC; Etzerodt M; Holtet TL
Protein Expr Purif; 2005 Jan; 39(1):18-26. PubMed ID: 15596356
[TBL] [Abstract][Full Text] [Related]
36. Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins.
Whitehead SS; Hruby DE
Virology; 1994 Apr; 200(1):154-61. PubMed ID: 8128619
[TBL] [Abstract][Full Text] [Related]
37. Characterization of cleavage sites and protease activity in the polyprotein precursor of Japanese marine aquabirnavirus and expression analysis of generated proteins by a VP4 protease activity in four distinct cell lines.
Imajoh M; Goto T; Oshima S
Arch Virol; 2007; 152(6):1103-14. PubMed ID: 17334948
[TBL] [Abstract][Full Text] [Related]
38. Processing of Escherichia coli alkaline phosphatase: role of the primary structure of the signal peptide cleavage region.
Karamyshev AL; Karamysheva ZN; Kajava AV; Ksenzenko VN; Nesmeyanova MA
J Mol Biol; 1998 Apr; 277(4):859-70. PubMed ID: 9545377
[TBL] [Abstract][Full Text] [Related]
39. The P1' specificity of tobacco etch virus protease.
Kapust RB; Tözsér J; Copeland TD; Waugh DS
Biochem Biophys Res Commun; 2002 Jun; 294(5):949-55. PubMed ID: 12074568
[TBL] [Abstract][Full Text] [Related]
40. High-level expression and purification of a recombinant human alpha-1, 3-fucosyltransferase in baculovirus-infected insect cells.
Shinkai A; Shinoda K; Sasaki K; Morishita Y; Nishi T; Matsuda Y; Takahashi I; Anazawa H
Protein Expr Purif; 1997 Aug; 10(3):379-85. PubMed ID: 9268686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
